IL2 and type 1 diabetes mellitus: Given the promising data of LD IL-2 in patients with HCV, GVHD, and Alopecia areata, there is great interest in giving LD IL-2 to patients with T1D to specifically boost Treg numbers and activity (15, 16, 62).